CEO/CFO Purchases Above 25K Insider Trading Activity Insider Trading Activity
The top officers spent at least $25K buying the company's stock.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CEO/CFO Purchases Above 25K Insider Trading Activity
Updated May 20, 2024
The top officers spent at least $25K buying the company's stock.
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identiv, Inc.
| 10K |
$4.15 | $41,500.00 | +5.50% | 191.94K |
May 17
| |||||||
F&m Bank Corp
| 1.71K |
$15.51 | $26,529.84 | +9.21% | 20.27K |
Apr 26 - May 15
| |||||||
SrBancorp, Inc.
| 5K |
$9.20 | $45,980.74 | +49.02% | 15.2K |
May 17
| |||||||
CF Bankshares Inc.
| 2.29K |
$18.92 | $43,378.40 | +0.78% | 297.92K |
May 13 - May 14
| |||||||
Prospect Capital Corp
| 798.9K |
$5.48 | $4,377,477.41 | +1.23% | 65.79M |
May 10
| |||||||
DT Midstream, Inc.
| 400 |
$62.80 | $25,118.00 | +0.91% | 44.28K | +1 |
May 3
| ||||||
Hillenbrand, Inc.
| 2.4K |
$42.58 | $102,189.60 | +5.17% | 48.79K | +1 |
May 3
| ||||||
Earth Science Tech, Inc.
| 709.84K |
$0.10 | $68,759.01 | +0.59% | 121.12M |
May 2
| |||||||
Intel Corp
| 4K |
$31.42 | $125,673.60 | +12.79% | 35.27K |
Apr 29
| |||||||
Hertz Global Holdings, Inc
| 250K |
$4.46 | $1,114,100.00 | +13.09% | 2.16M |
Apr 30
| |||||||
Hawthorn Bancshares, Inc.
| 13.55K |
$18.66 | $44,774.00 | +75.79% | 31.43K |
Apr 29 - May 1
| |||||||
Earth Science Tech, Inc.
| 478.33K |
$0.08 | $41,128.94 | +0.13% | 360.33M |
Apr 29
| |||||||
Earth Science Tech, Inc.
| 478.33K |
$0.08 | $41,128.94 | +0.13% | 360.33M |
Apr 29
| |||||||
Hunt J B Transport Services Inc
| 6.2K |
$161.06 | $998,550.30 | +2.01% | 313.95K |
Apr 26
| |||||||
Inmune Bio, Inc.
| 18.03K |
$8.32 | $149,992.96 | +1.44% | 1.27M | +1 |
Apr 19
| ||||||
Mobile Infrastructure Corp
| 55.12K |
$3.39 | $186,843.24 | +107.81% | 106.24K |
Apr 19
|
Scheduled
| ||||||
Mobile Infrastructure Corp
| 33.04K |
$3.41 | $112,676.63 | +182.75% | 51.12K |
Apr 18
|
Scheduled
| ||||||
Cadiz Inc
| 25K |
$2.25 | $56,250.00 | +2.65% | 966.92K |
Apr 18
| |||||||
Mobile Infrastructure Corp
| 16.86K |
$3.45 | $58,170.45 | +1,382.05% | 18.08K |
Apr 17
|
Scheduled
| ||||||
Neogen Corp
| 12.5K |
$12.51 | $156,321.25 | +71.27% | 30.04K |
Apr 10
| |||||||
Neogen Corp
| 23K |
$12.36 | $284,190.30 | +17.78% | 152.39K |
Apr 10
| |||||||
Flora Growth Corp.
| 526.32K |
$1.90 | $999,998.50 | +1,335.86% | 565.71K |
Apr 8
| |||||||
Dominari Holdings Inc.
| 17.44K |
$2.82 | $49,162.50 | +17.66% | 116.25K |
Apr 4 - Apr 5
| |||||||
Sow Good Inc.
| 17.24K |
$7.25 | $125,004.50 | +6.42% | 285.99K |
Mar 28
| |||||||
Mirum Pharmaceuticals, Inc.
| 2K |
$24.80 | $49,600.00 | +16.67% | 14K |
Mar 27
| |||||||
Harrow, Inc.
| 9K |
$11.59 | $104,310.00 | +0.42% | 2.14M |
Mar 22
| |||||||
Himalaya Technologies, Inc
| 24.39M |
—
| $25,680.00 |
∞
| 24.39M | +2 |
Apr 12 - Feb 16
| ||||||
Ovid Therapeutics Inc.
| 18.25K |
$2.76 | $50,364.48 | +0.51% | 3.62M |
Mar 18
| |||||||
Himalaya Technologies, Inc
| 24.39M |
—
| $25,680.00 |
∞
| 24.39M | +2 |
Apr 12 - Feb 16
| ||||||
Latham Group, Inc.
| 27.5K |
$2.92 | $80,300.00 | +10.36% | 292.92K |
Mar 15
| |||||||
Rezolute, Inc.
| 20K |
$1.69 | $33,830.00 |
∞
| 20K |
Mar 15
| |||||||
Trinity Capital Inc.
| 3.35K |
$14.91 | $49,993.05 | +0.41% | 821.48K | +1 |
Mar 14
| ||||||
Mirum Pharmaceuticals, Inc.
| 2K |
$25.80 | $51,600.00 | +20.00% | 12K |
Mar 18
| |||||||
Upexi, Inc.
| 77.77K |
$0.58 | $44,739.30 | +2.72% | 2.94M |
Mar 11 - Mar 12
| |||||||
Alx Oncology Holdings Inc
| 4.4K |
$11.31 | $49,771.48 | +2.63% | 171.62K |
Mar 14
| |||||||
Prospect Capital Corp
| 5K |
$5.44 | $27,199.50 | +100.00% | 10K | +3 |
Mar 11
| ||||||
United Natural Foods Inc
| 6.28K |
$11.99 | $75,237.25 | +3.62% | 179.82K |
Mar 11
| |||||||
Nautilus Biotechnology, Inc.
| 14.47K |
$2.87 | $41,477.85 | +0.14% | 10.06M | +2 |
Mar 8 - Mar 11
| ||||||
Fibrogen Inc
| 50K |
$1.91 | $95,470.00 | +11.90% | 470.18K |
Mar 7
| |||||||
Revance Therapeutics, Inc.
| 30K |
$6.98 | $209,400.00 | +3.04% | 1.02M |
Mar 6
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.